Exporting Medical Devices to Ireland: ÜTS, EUDAMED, CE and Label Language
Ireland is the only EU Member State that allows the label and instructions for use in English only, which means a market a Turkish manufacturer can enter directly with its existing English document set. This page brings together HPRA's registration pages, the Commission language table, MDCG 2022-16 and the ÜTS rules for a manufacturer established in Türkiye that will export medical devices to Ireland.
HPRA's Definition of a Non-EU Manufacturer and Türkiye
HPRA's page for non-EU manufacturers describes a non-EU manufacturer registering its device in EUDAMED and linking its organisation to an authorised representative established in Ireland; the page title states that this information is for non-EU manufacturers that have an authorised representative in Ireland. A manufacturer established in Türkiye does not fall into this group.
"'Union market' means the territory of the European Union Member States and is extended to Norway, Liechtenstein and Iceland because of the European Economic Area (EEA) and to Türkiye through the Customs Union Agreement."
Source: MDCG 2022-16, Turkish translation, footnote 1.
The definition of authorised representative is as follows:
"Authorised representative: a person established in the Union, who has received and accepted a written mandate from a manufacturer established outside the Union, to act on the manufacturer's behalf in relation to specified tasks with regard to the latter's obligations under this Regulation"
Source: Definitions section, MDCG 2022-16 (Turkish translation).
Medical Device Regulation Article 11(1):
"Where the manufacturer is not established in Türkiye or an EU member state, the device may be placed on the market only on the condition that the manufacturer appoints an authorised representative."
Source: Medical Device Regulation (Official Gazette 31499), Article 11, paragraph 1.
The Irish buyer is shown the EUDAMED manufacturer registration; no authorised representative link is made. Authorised representation applies only to manufacturers outside Türkiye and the EU.
Label and Instructions for Use Language: English (or English and Irish)
"Manufacturers shall ensure that the device is accompanied by the information set out in Section 23 of Annex I in an official Union language(s) determined by the Member State in which the device is made available to the user or patient. The particulars on the label shall be indelible, easily legible and clearly comprehensible to the intended user or patient."
Source: (EU) 2017/745 (MDR), Article 10(11).
For Ireland, the Commission language table points to S.I. No. 547/2017 European Union (Medical Devices and In Vitro Diagnostic Medical Devices) Regulations 2017: the label and instructions for use, implant card, declaration of conformity, field safety notice and conformity assessment certificates in English or in English and Irish (No 5 (a)). There is no difference between patient and professional users.
For a manufacturer in Türkiye, this means the English label and IFU in the technical file can be used directly in Ireland. Irish is an option, not an addition. The Turkish label rule in ÜTS is explained in the article on Turkish label and instructions for use for supply to Türkiye; Turkish content on a product going to Ireland does not affect the English requirement.
HPRA: EUDAMED Verification and National Distributor Registration
Ireland's competent authority is the Health Products Regulatory Authority (HPRA, Dublin); it appears for the MDR and IVDR in the Commission's May 2026 national authority list. According to HPRA's registration pages, the division of tasks is as follows: HPRA verifies EUDAMED applications for manufacturers, authorised representatives and their non-EU manufacturers established in Ireland, importers and system/procedure pack producers, and the SRN is obtained from EUDAMED; distributors and manufacturing sites established in Ireland register nationally with HPRA and receive an HPRA registration number. The distributor page asks distributors established in Ireland to register their company details and device types nationally through HPRA's online form; the national basis is S.I. 691/2021 Medical Devices (Registration) Regulations 2021 and, for IVDs, S.I. 365/2022. An annual maintenance fee is charged to all registered economic operators, and an additional administrative fee is requested from those registering directly with HPRA.
Result for a manufacturer in Türkiye: no national registration with HPRA is made; the EUDAMED registration is verified by the manufacturer's own competent authority under MDR Article 31(2). The Irish distributor makes its own registration under S.I. 691/2021 and reports its device types.
"Member States may maintain or introduce national provisions on registration of distributors of devices which have been made available on their territory."
Source: Medical Device Regulation (EU) 2017/745, Article 30(2).
EUDAMED Registration for the Irish Market
HPRA's non-EU manufacturer page directs to the EUDAMED actor and device modules; the same registration path applies to a manufacturer in Türkiye, except for the authorised representative link.
"Before placing a device, other than a custom-made device, on the market, manufacturers, authorised representatives and importers shall, in order to register, submit to the electronic system referred to in Article 30 the information referred to in Section 1 of Part A of Annex VI, provided that they have not already registered in accordance with this Article."
Source: MDR, Article 31, paragraph 1.
"After having verified the data entered pursuant to paragraph 1, the competent authority shall obtain a single registration number ('SRN') from the electronic system referred to in Article 30 and issue it to the manufacturer, the authorised representative or the importer."
Source: MDR, Article 31, paragraph 2.
"Before placing a device, other than a custom-made device, on the market, the manufacturer shall, in accordance with the rules of the issuing entity referred to in Article 27(2), assign a Basic UDI-DI as defined in Part C of Annex VI to the device and shall provide it to the UDI database together with the other core data elements referred to in Part B of Annex VI related to that device."
Source: Medical Device Regulation (EU) 2017/745, Article 29(1).
The phased application provision of (EU) 2024/1860:
"no later than 12 months from the date of publication of the notice referred to in Article 34(3) in respect of the electronic system referred to in Article 33(2), points (a) and (b), manufacturers shall ensure that the information to be entered in Eudamed in accordance with Article 29 is entered in that electronic system, including regarding the following devices, provided that those devices are also placed on the market from 6 months from the date of publication of that notice:"
Source: Regulation (EU) 2024/1860, Article 1(3)(b); amended provision MDR Article 123(3)(e).
According to the Commission's EUDAMED page, Decision (EU) 2025/2371 was published on 27 November 2025 and the four modules became mandatory from 28 May 2026; the 12-month period for device data ends at the end of November 2026. The steps are in the articles on EUDAMED actor registration, device registration and legacy device registration; service details at EUDAMED registration consultancy.
ÜTS Notification and Free Sale Certificate for Exports to Ireland
A shipment to Ireland can go by air or by road via the United Kingdom; UK transit does not affect the ÜTS notification, what matters is the export declaration in Türkiye.
"An 'Export Notification' is made for individual products exported by the company."
Source: Guide on Individual Movement Notifications of the Medical Device Tracking System (TİTCK), Article 17(1).
"When making an Export Notification in ÜTS, after querying by product number, lot and/or serial number, entering data in the Customs Declaration number and Quantity fields is mandatory."
Source: Guide on Individual Movement Notifications of the Medical Device Tracking System (TİTCK), Article 17(2).
"If the Export Notification was made incorrectly, it is cancelled with an 'Export Cancellation Notification'."
Source: Guide on Individual Movement Notifications of the Medical Device Tracking System (TİTCK), Article 17, paragraph 3.
The notification procedure is in the articles on ÜTS individual movement notifications and on exports, free zones and bonded warehouses in ÜTS; the service is on the individual notification procedures page.
HPRA's free sale certificate page is for manufacturers established in Ireland; a manufacturer in Türkiye obtains the certificate from ÜTS.
"Free Sale Certificate: the certificate issued by the Authority at the request of the domestic manufacturer or of the Türkiye-based EU authorised representative of a foreign manufacturer, in order to be able to export devices covered by the Medical Device Regulations, which declares that the relevant devices bearing the CE marking can be marketed in Türkiye and EU member states."
Source: ÜTS Registration Guide TCKKD-KLVZ-03 V4.0, Article 4 (Definitions), item (zz).
The application is in the free sale certificate article. Other professional markets that can be entered with an English IFU: the Netherlands and Germany.
Ireland summary table
TopicStatusCompetent authorityHPRA (Health Products Regulatory Authority), DublinLabel / IFU languageEnglish or English and Irish, the same for patient and professional users (S.I. 547/2017 No 5 (a))National additional registration / notificationA distributor established in Ireland registers nationally with HPRA (S.I. 691/2021); for a manufacturer in Türkiye there is no national registration, the EUDAMED registration is what matters. Is an AR requiredNo (manufacturer established in Türkiye, Customs Union; MDCG 2022-16 footnote 1)
Medical Device ÜTS Registration Consultancy for exports to Ireland
We handle the ÜTS product registration, export notifications and EUDAMED actor and device registration of manufacturers exporting to Ireland; we check that the English label and IFU are consistent with the EUDAMED data. To define the scope together, get a price quote, call +90 505 580 46 22 or write to info@medexmedikal.com.
Frequently Asked Questions
Can I sell in Ireland with my existing English label?
Yes. According to the Commission language table, S.I. 547/2017 No 5 (a) provides for the label and instructions for use in English or in English and Irish; there is no distinction between patient and professional users.
Does HPRA's page for non-EU manufacturers apply to me?
No. That page is for non-EU manufacturers that have an authorised representative established in Ireland. MDCG 2022-16 footnote 1 states that the Union market covers Türkiye through the Customs Union; a manufacturer established in Türkiye registers in EUDAMED directly as a manufacturer and makes no authorised representative link.
Does my Irish distributor need to register with HPRA?
Yes. According to HPRA's distributor page, distributors established in Ireland register their company details and device types nationally through HPRA's online form (S.I. 691/2021) and receive an HPRA registration number; an annual maintenance fee applies.
Does HPRA verify my EUDAMED application?
No. HPRA verifies EUDAMED applications only for manufacturers, authorised representatives and their non-EU manufacturers established in Ireland, importers, and system/procedure pack producers. Under MDR Article 31(2), the SRN is issued by the manufacturer's own competent authority.
Does the ÜTS notification change for a consignment going by road via the United Kingdom?
No. Under Article 17 of the Individual Movement Notifications Guide, the Export Notification is made with the customs declaration number in Türkiye and the quantity; the transit route does not require a separate notification in ÜTS.
